Home

aidsmap HIV & AIDS news

• For patients with HIV viral load is key in immune response to yellow fever vaccine

  Immunisations
  Michael Carter | 02 February 2012

  Viral load is the only factor associated with a poorer antibody response to the yellow fever vaccine in patients with HIV, according to a French study published in the online edition of ...

• Contraception in HIV prevention trials: injectable hormonal methods more effective?

  Contraception
  Carole Leach-Lemens | 02 February 2012

  Women using injectable (hormonal) contraceptives had a significantly lower rate of pregnancy compared to those using oral contraception in a major HIV prevention study, researchers report in the advance online edition of ...

• Men who have sex with men may now be the highest-risk group for HIV in Africa, IAVI study suggests

  Men who have sex with men (MSM)
  Gus Cairns | 01 February 2012

  Men who have sex with men may now be at considerably higher risk of acquiring HIV than other at-risk groups such as female sex workers or young people of either sex, if ...

• HIV care providers in US struggling to cope with rising patient numbers

  Delivery of care
  Michael Carter | 01 February 2012

  HIV doctors in the US are struggling to meet the demands of a rising patient caseload, according to the findings of a national survey. Two-thirds of HIV treatment providers reported an increase in ...

• Quarter of men resume sex before wounds from circumcision fully healed in Zambian study

  Circumcision
  Michael Carter | 31 January 2012

  Approximately a quarter of men undergoing circumcision resume sexual activity before their wounds have fully healed, Zambian research published in the online edition of AIDS shows. Most of the men reporting the early ...

• Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use

  PEP
  Michael Carter | 31 January 2012

  Raltegravir could have a “useful” role in HIV post-exposure prophylaxis, according to investigators from the US writing in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Doctors in Boston, Massachusetts, ...

• For study participants, PrEP was an opportunity to save their relationship

  PrEP
  Roger Pebody | 30 January 2012

  Seeking to understand why adherence to pre-exposure prophylaxis (PrEP) was extremely high in a study of serodiscordant couples, qualitative researchers have found that trial participants saw PrEP as a way they could preserve ...